Patent assignee · US · COMPANY

COCRYSTAL PHARMA, INC.

🏢 View company profile →
16Patents
16Active
16Granted
50Portfolio score

Filing activity: Jan 11, 2013 → Nov 13, 2019

Most-cited patents

PatentTitleAreaCited byStatus
US9173893B2 Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infections Emerging Cross-Sectional Technologies 29 Active
US9809616B2 Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer Chemistry; Metallurgy 13 Active
US10464914B2 Inhibitors of hepatitis C virus polymerase Human Necessities 2 Active
US11014941B2 Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication Human Necessities 2 Active
US9932326B2 Potent and selective inhibitors of hepatitis C virus Chemistry; Metallurgy 1 Active
US10947210B2 Inhibitors of Hepatitis C virus polymerase Human Necessities 1 Active
US12357631B2 Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replication Chemistry; Metallurgy 0 Active
US11752166B2 Combination therapy for treatment of HCV Human Necessities 0 Active
US12233066B2 Combinations of inhibitors of influenza virus replication Human Necessities 0 Active
US12037333B2 Pyridopyrazine and pyridotriazine inhibitors of influenza virus replication Human Necessities 0 Active
US10011629B2 Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer Emerging Cross-Sectional Technologies 0 Active
US10426762B2 Inhibitors of hepatitis C virus polymerase Chemistry; Metallurgy 0 Active
US9181227B2 Potent and selective inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
US9926295B2 Potent and selective inhibitors of hepatitis C virus Chemistry; Metallurgy 0 Active
US9040479B2 HCV NS3 protease inhibitors Chemistry; Metallurgy 0 Active
US12156876B2 Formulations of influenza therapeutics Human Necessities 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.